Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Hers vs Nurx

Nurx costs $20 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Hers logo

Hers

7.0
★★★★☆3.5/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Hers →
VS
Nurx logo

Nurx

4.8
★★☆☆☆2.4/5
Visit Nurx →

If you are choosing between Hers and Nurx, the first difference is cost: Nurx is $20 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hers leads our six-part score, 7.0 to 4.8.

Hers vs Nurx price

Nurx is the cheaper way in: $179 a month against $199 a month at Hers. That is $20 less each month (10% lower), or about $240 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Nurx ($179 a month vs $199 a month); tirzepatide is cheaper at Nurx ($179 a month vs $299 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Hers prices compounded injections and brand-name pens, while Nurx prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.

Where each one treats patients

Hers lists 50 states, and Nurx does not publish where it ships.

Pricing

Hers

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)

Nurx

StartingCompounded
$179/mo
semaglutide

Range up to $299/mo

StartingCompounded
$179/mo
tirzepatide

Range up to $299/mo

What each price covers

Hers' price also covers the medication itself, which Nurx does not claim.

Hers is silent on shipping and lab work.

Nurx is silent on shipping, lab work and coaching.

That matters most for the drug: unless Nurx confirms otherwise, budget for medication on top of its listed price.

Hers

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

Nurx

Covered by the monthly price

Medication

Charged on top

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Hers scores 7.0 and Nurx 4.8 out of 10.

Hers is stronger on user experience (8.0 vs 3.0), trust & safety (8.5 vs 4.0), accessibility (10.0 vs 5.0) and support (3.0 vs 0.0).

Value and effectiveness are within half a point.

How we score

Hers

7.0/10

Overall

Nurx

4.8/10

Value25%

3.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

8.5A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

3.0A
vs
B
0.0

FDA warning letters

Neither Hers nor Nurx has an FDA warning letter on record with us.

Features & Coverage

FeatureHersNurx
Starting Price$199/mo✓$179/mo
Features2 features✓3 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Hers

Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.

Read our full Hers review →

About Nurx

Nurx is an established women's telehealth brand running tiered GLP-1 weight loss programs.

Read our full Nurx review →

Pros & Cons

Hers

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states
  • We found no FDA warning letters issued to Hers

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Nurx

What we like

  • We found no FDA warning letters issued to Nurx

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Not included in the monthly price: medication, clinician visits
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Hers

Hers wins this one, 7.0 to 4.8, above all for coverage in all 50 states, which most sellers will not confirm. Nurx undercuts it by $20 a month, so if the monthly bill is what decides it, Nurx is the pick.

Choose Hers if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.

Choose Nurx if…

You want the lower starting price and an opening price near $179 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.6

Breeze Meds

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

7.7

HealthRX

Compounded semaglutide at $133/month

7.3

RNK Health

An oral route if you will not self-inject

Hers vs Nurx: FAQ

Nurx. It starts at $179 a month; Hers starts at $199 a month, $20 more per month.
Yes, both sell semaglutide and tirzepatide.
Hers lists 50 states; Nurx does not publish where it ships. Confirm your state before paying.
Only Hers includes the medication itself.
Hers has none. Nurx has none.
No. Neither Hers nor Nurx pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.